Villejuif, France

Vladimir Lazar

USPTO Granted Patents = 4 

 

 

Average Co-Inventor Count = 2.3

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2001-2021

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Vladimir Lazar: Innovator in Cancer Treatment

Introduction

Vladimir Lazar is a notable inventor based in Villejuif, France. He has made significant contributions to the field of cancer treatment through his innovative methods and approaches. With a total of 4 patents, Lazar's work focuses on personalized medicine and the optimization of drug therapies for cancer patients.

Latest Patents

One of his latest patents is a method for selecting personalized tri-therapy for cancer treatment. This invention relates to determining the best combinations of at least three drugs for treating cancer, based on identifying the most relevant intervention points for an individual. Another significant patent involves computer-implemented methods of treating lung cancer. This invention predicts the relative efficacy of multiple drugs for treating a tumor in an individual by molecularly characterizing the tumor and calculating a score for the drugs based on the percentage of deregulated target genes.

Career Highlights

Throughout his career, Lazar has worked with prominent organizations such as the Worldwide Innovative Network and the Institut Gustave Roussy. His experience in these institutions has allowed him to develop and refine his innovative approaches to cancer treatment.

Collaborations

Lazar has collaborated with esteemed colleagues, including Dominique Bellet and Jean-Michel Bidart. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Vladimir Lazar's contributions to cancer treatment through his innovative patents highlight his commitment to improving patient outcomes. His work exemplifies the importance of personalized medicine in the fight against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…